The Indian Pharmacopoeia Commission has published the Indian Pharmacopoeia 2022 to supplement the current Indian Pharmacopoeia – the book of standards under the Drugs and Cosmetics Act,1940. IP 2022 is likely to be effective from December 1, 2022.
2022 Regulatory Activity in the Pharmaceutical Sector of India natlawreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from natlawreview.com Daily Mail and Mail on Sunday newspapers.
In India, biotechnology has played an important role in helping stakeholders in academia, industry, and government develop new pandemic-related technology, from test kits to respiratory devices. But these biotechnology advancements can go further to strengthen India’s public health capacity.
The Drugs Controller General of India (DCGI) has approved Serum Institute of India's proposal to manufacture a vaccine against the Omicron variant of coronavirus for examination, test and analysis, official sources said on Monday.